Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-27

Clinical Trial Update: A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers [Phase 2]

View source ↗

Summary

Phase II feasibility study results for the treatment of resected cholangiocarcinoma, gallbladder cancer, pancreatic cancer, and ampullary cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Cholangiocarcinoma Cancer, Gallbladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-27